Navigation Links
WEDI Applauds X12 for New Public Review Option of HIPAA Standards
Date:3/15/2017

The Workgroup for Electronic Data Interchange (WEDI), the nation’s leading nonprofit authority on the use of health IT to create efficiencies in healthcare information exchange and a trusted advisor to the U.S. Department of Health and Human Services (HHS), strongly supports the decision by X12 to offer downloadable PDFs to facilitate public review of the 7030 version of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) electronic transactions. The first cycle offering the PDF download option is Cycle 4, which includes the 837 Health Care Claim transactions. Cycle 4 runs through June 1, 2017.

“Implementation of the latest version of the HIPAA electronic standards presents a significant opportunity for providers and health plans to realize operational efficiencies,” stated Charles W. Stellar, president and CEO of WEDI. “However, if the healthcare industry is to improve upon the current version of the transactions, a thorough public review of these highly technical draft transaction standards is essential. We commend the X12 leadership for facilitating an open and effective review process by offering downloadable PDFs to stakeholders seeking to evaluate these draft standards and provide comment.”

About WEDI
The Workgroup for Electronic Data Interchange (WEDI) is the leading authority on the use of health IT to improve healthcare information exchange in order to enhance the quality of care, improve efficiency, and reduce costs of our nation’s healthcare system. WEDI was formed in 1991 by the Secretary of Health and Human Services (HHS) and was designated in the 1996 HIPAA legislation as an advisor to HHS. WEDI’s membership includes a broad coalition of organizations, including: hospitals, providers, health plans, vendors, government agencies, consumers, not-for-profit organizations, and standards development organizations. To learn more, visit http://www.wedi.org and connect with us on Twitter, Facebook and LinkedIn.

###

Read the full story at http://www.prweb.com/releases/2017/03/prweb14147896.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Americord Applauds Study on Stem Cell Therapy for Congenital Heart Defects
2. Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries
3. Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on Repealing Prohibition, Again; NYT Editorial Is Bell Weather of Change
4. Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap
5. Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding
6. Biocom Applauds Passage of 21st Century Cures Legislation
7. UCB and Emory partner to address pressing public health issues for people living with epilepsy
8. BioTechniques: The International Journal of Life Science Methods Announces the Publication of the March 2013 Digital Edition Now Available Online and in the App Store
9. Suspect Detection Systems Receives Funding From Israel-Publicly Traded Biomedix Ltd.
10. Pesticide-Exempt Bed Bug Spray Offered to Public After Bed Bugs Troubled a Lincoln Care Facility, My Cleaning Products Relates How to Get One
11. Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer ... hire of Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. ... development activities. , “Dr. Floyd’s career has spanned 30 years in the chemicals ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
Breaking Biology Technology:
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
Breaking Biology News(10 mins):